Generic Clearance to Collect Medical Outcome and Risk Factor Data from a Cohort of U.S. Radiologic Technologists

ICR 200702-0925-002

OMB: 0925-0405

Federal Form Document

Forms and Documents
Document
Name
Status
Supplementary Document
2007-08-15
Supplementary Document
2007-07-26
Supplementary Document
2007-08-15
Supplementary Document
2007-07-26
Supporting Statement B
0000-00-00
Supplementary Document
0000-00-00
Supplementary Document
2007-08-15
Supporting Statement A
0000-00-00
IC Document Collections
IC ID
Document
Title
Status
ICR Details
0925-0405 200702-0925-002
Historical Active 200311-0925-002
HHS/NIH
Generic Clearance to Collect Medical Outcome and Risk Factor Data from a Cohort of U.S. Radiologic Technologists
Revision of a currently approved collection   No
Regular
Approved with change 02/06/2008
Retrieve Notice of Action (NOA) 02/28/2007
This latest ICR request (i.e. to add on blood/DNA testing as part of this overall generic ICR) is withdrawn per NIH request. Should NIH decide to pursue this particular part of the study, NIH shall revise its HIPAA and consent forms so that the study--as it is described on those forms--is consistent with how it is described in the supporting statement, particularly with regard to privacy protocols (i.e. under what circumstances--and to whom--private health information shall be disclosed) and the storage/banking of specimens for future research. Moreover, the HIPAA and consent forms shall be revised to better protect the privacy of respondents' sensitive health information. Upon resubmission of this ICR, NIH will have obtained IRB approval for these changes. Previous terms of clearance remain in effect. NIH is also authorized to carry on with other aspects of this generic clearance which have already been approved. It is only the latest ICR request that is withdrawn at this time.
  Inventory as of this Action Requested Previously Approved
02/28/2011 36 Months From Approved 02/29/2008
5,630 0 59,200
5,630 0 29,500
0 0 0

U.S. radiologic technologists who are participants in an ongoing cohort study will be asked to respond to occasional surveys to ascertain incident cancers, benign conditions associated with high risk of cancer, and selected other health outcomes, as well as demographic, lifestyle, reproductive, employment, and other characteristics that may influence health risks. The primary aim of this project is to substantially increase knowledge about the long-term health effect associated with protracted low- to moderate-dose radiation exposures.

US Code: 42 USC 411 Name of Law: National Cancer Program
  
None

Not associated with rulemaking

  71 FR 78445 12/29/2006
72 FR 9010 02/28/2007
No

0

  Total Approved Previously Approved Change Due to New Statute Change Due to Agency Discretion Change Due to Adjustment in Estimate Change Due to Potential Violation of the PRA
Annual Number of Responses 5,630 59,200 0 -53,570 0 0
Annual Time Burden (Hours) 5,630 29,500 0 -23,870 0 0
Annual Cost Burden (Dollars) 0 0 0 0 0 0
No
Yes
Miscellaneous Actions
The previous annual burden was 29,500. We are now asking for 5,630, which is a minus 23,870. The decrease relates to the fact that we plan to conduct only one survey under this approval rather than the three requested under the generic clearance.

$400,000
Yes Part B of Supporting Statement
No
Uncollected
Uncollected
Uncollected
Uncollected
Saleda Perryman

  No

On behalf of this Federal agency, I certify that the collection of information encompassed by this request complies with 5 CFR 1320.9 and the related provisions of 5 CFR 1320.8(b)(3).
The following is a summary of the topics, regarding the proposed collection of information, that the certification covers:
 
 
 
 
 
 
 
    (i) Why the information is being collected;
    (ii) Use of information;
    (iii) Burden estimate;
    (iv) Nature of response (voluntary, required for a benefit, or mandatory);
    (v) Nature and extent of confidentiality; and
    (vi) Need to display currently valid OMB control number;
 
 
 
If you are unable to certify compliance with any of these provisions, identify the item by leaving the box unchecked and explain the reason in the Supporting Statement.
02/28/2007


© 2024 OMB.report | Privacy Policy